NORTHERN TRUST CORP - CYCLERION THERAPEUTICS INC ownership

CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 77 filers reported holding CYCLERION THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of CYCLERION THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$35,055
-33.9%
80,7920.0%0.00%
Q4 2022$53,016
-23.2%
80,7920.0%0.00%
Q3 2022$69,000
+56.8%
80,7920.0%0.00%
Q2 2022$44,000
-51.1%
80,7920.0%0.00%
Q1 2022$90,000
-35.3%
80,7920.0%0.00%
Q4 2021$139,000
-36.8%
80,792
+12.4%
0.00%
Q3 2021$220,000
-12.7%
71,880
+11.2%
0.00%
Q2 2021$252,000
-62.2%
64,616
-73.0%
0.00%
Q1 2021$667,000
-15.2%
239,015
-7.0%
0.00%
Q4 2020$787,000
-51.4%
257,044
-3.4%
0.00%
Q3 2020$1,618,000
+11.1%
266,093
+8.0%
0.00%
Q2 2020$1,456,000
+100.8%
246,442
-10.0%
0.00%
Q1 2020$725,000
-7.1%
273,741
-4.6%
0.00%
Q4 2019$780,000
-77.3%
286,960
+1.3%
0.00%
-100.0%
Q3 2019$3,433,000
+57.8%
283,294
+49.0%
0.00%0.0%
Q2 2019$2,176,000
+1218.8%
190,151
+1681.4%
0.00%
Q1 2019$165,00010,6740.00%
Other shareholders
CYCLERION THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
AWH Capital, L.P. 325,000$861,0004.66%
MFN Partners Management, LP 2,427,677$6,433,0000.85%
EcoR1 Capital, LLC 2,742,276$7,267,0000.76%
Slate Path Capital LP 1,196,063$3,170,0000.24%
Eversept Partners, LP 337,145$893,4340.22%
Artal Group S.A. 1,861,584$4,933,0000.21%
Alambic Investment Management, L.P. 21,265$56,0000.14%
TRUSTCORE FINANCIAL SERVICES, LLC 198,106$525,0000.12%
SPHERA FUNDS MANAGEMENT LTD. 124,976$331,0000.04%
Broderick Brian C 32,175$86,0000.03%
View complete list of CYCLERION THERAPEUTICS INC shareholders